NIH-funded research NIH-funded research

Investigating how glucocorticoids affect outcomes in critically ill patients

Official title: Glucocorticoids in short- and long-term critical illness outcomes

Funded at University of Michigan at Ann Arbor · NIH-11121086 · Data updated 2026-11-12

This study is looking at how a type of steroid hormone called glucocorticoids can help improve recovery for people who have been very sick, especially focusing on how it affects their mental health and memory after sepsis, so we can make this treatment work better for them.

More Critical Illness research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startJuly 1, 2024
Project endApril 30, 2029
Funding year2025
Award (this year)$390,000
NIH project number5R35GM154671-02
Project IDNIH-11121086 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include patients who have survived sepsis or are experiencing critical illness requiring glucocorticoid treatment.

Less likely to help

Patients with non-critical illnesses or those not receiving glucocorticoid therapy may not benefit from this research.

What this research studies

This research focuses on understanding how glucocorticoids, a type of steroid hormone, can improve outcomes for patients suffering from critical illnesses. The study will explore the biological mechanisms behind glucocorticoid treatment, particularly its effects on mental health and memory in sepsis survivors. Researchers will also investigate how glucocorticoid signaling in the brainstem influences cardiovascular and immune responses during critical health challenges. By addressing these areas, the research aims to enhance the effectiveness of glucocorticoid therapy in critically ill patients.

Why it matters

Potential benefit: If successful, this research could lead to improved survival rates and better mental health outcomes for critically ill patients.

How similar studies have gone: Previous research has shown promising results regarding the use of glucocorticoids in critical illness, indicating that this approach has potential for significant impact.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Spencer-Segal, Joanna Louise — University of Michigan at Ann Arbor
  • Study coordinator: Spencer-Segal, Joanna Louise

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.